Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When patients request the impotence pill

D F Mobley1, N Baum

  • 1Department of Surgery, Memorial City Medical Center, Houston, USA.

Postgraduate Medicine
|August 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testing the factor structure of the Family Quality of Life Survey - 2006.

Journal of intellectual disability research : JIDR·2011
Same author

The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis.

Oncogene·2009
Same author

Family quality of life among families with a member who has an intellectual disability: an exploratory examination of key domains and dimensions of the revised FQOL Survey.

Journal of intellectual disability research : JIDR·2009
Same author

Quality of life is not only for people served--it is also for staff: the Multi-Focal Approach.

Journal of intellectual disability research : JIDR·2005
Same author

Practice automation and medical errors.

Cost & quality : CQ·2001
Same author

Prostaglandin E1 versus sex therapy in the management of psychogenic erectile dysfunction.

International journal of impotence research·2000
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
See all related articles

Erectile dysfunction (ED) affects many men over 50. Increased awareness is driving more men to seek treatment, with options ranging from primary care to urology referrals and new therapies on the horizon.

Area of Science:

  • Urology
  • Andrology
  • Men's Health

Background:

  • Erectile dysfunction (ED) is a prevalent condition, particularly in men over 50.
  • Public awareness of ED therapies has increased, leading more men to seek medical help.
  • Primary care physicians can manage initial ED treatments, with urologists available for complex cases.

Purpose of the Study:

  • To review the current landscape of erectile dysfunction treatments.
  • To highlight the accessibility of first-line therapies in primary care.
  • To discuss the progression of ED treatment options and future developments.

Main Methods:

  • Review of existing medical literature on erectile dysfunction.
  • Analysis of current treatment modalities available for ED.

Related Experiment Videos

  • Discussion of the role of primary care physicians and urologists in ED management.

    • Main Results:

    • First-line ED treatments are often manageable in primary care settings.
    • Patients dissatisfied with initial treatments may require referral to a urologist.
    • Novel therapeutic agents for ED are under development, targeting both peripheral and central mechanisms.

    Conclusions:

    • Erectile dysfunction management is evolving with increased patient engagement.
    • A spectrum of treatment options exists, from oral medications to advanced therapies.
    • Future advancements promise more pharmacologic interventions for ED.